Haemophilus influenzae Type b conjugate Vaccine (Beijing Kexing Zhongwei)

b型流感嗜血杆菌结合疫苗（科兴中维）

Report date: 2024/07/08 14:15:37

Base Information

Drug NameHaemophilus influenzae Type b conjugate Vaccine (Beijing Kexing Zhongwei)
Drug Alias NameN/A
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSinovac Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG